Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.5655
+0.0155 (2.82%)
At close: May 12, 2025, 4:00 PM
0.5739
+0.0084 (1.49%)
After-hours: May 12, 2025, 7:11 PM EDT
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Unicycive Therapeutics stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 7.50. The average target predicts an increase of 872.59% from the current stock price of 0.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Unicycive Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +961.01% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7.5 | Strong Buy | Reiterates | $7.5 | +1,226.26% | Apr 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $7.5 | Strong Buy | Maintains | $4 → $7.5 | +1,226.26% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +607.34% | Jan 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +607.34% | Jan 8, 2025 |
Financial Forecast
Revenue This Year
20.28M
Revenue Next Year
306.30M
from 20.28M
Increased by 1,410.65%
EPS This Year
-0.28
from -0.56
EPS Next Year
0.97
from -0.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 45.7M | 522.5M | 1.2B | ||
| Avg | 20.3M | 306.3M | 593.0M | ||
| Low | 4.1M | 200.3M | 163.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 2,477.1% | 290.1% | ||
| Avg | - | 1,410.7% | 93.6% | ||
| Low | - | 887.8% | -46.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.04 | 1.72 | 3.85 | ||
| Avg | -0.28 | 0.97 | 2.01 | ||
| Low | -0.42 | 0.43 | 0.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 297.7% | ||
| Avg | - | - | 107.7% | ||
| Low | - | - | -72.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.